This is not your average accelerator.
The Mayo Clinic Platform_Accelerate has developed a 20-week course to help start-up health tech AI companies develop their go to market strategies.
Your company can get valuable assistance and data from Mayo Clinic Platform_Accelerate (although in my humble opinion, they need a better name) by providing in-kind investments such as datasets and validation tools; and traditional accelerator tools such as mentoring, pitch deck development, access to investors, etc. Mayo Clinic Platform gets its cut of course, they expect an equity position in your startup based on your most recent valuation.
There is a selection process and not every company will pass muster. Selected companies will work with data science experts to outline AI model requirements, scrub for bias and fairness, and acquire insights into FDA clearance pathways.
Most unique is that selected companies will gain access to de-identified Mayo Clinic patient data, and potentially plan clinical studies and/or explore the potential to partner with Mayo Clinic Platform.
A waitlist is open for the second Mayo Clinic Platform_Accelerate cohort, which is planned to begin in summer 2022.
Resources
Mayo Clinic Platform_Accelerate Website
Application (Application Deadline: May 9, 2022)
Email: mcp-accelerate@mayo.edu
If you have medtech AI technology, we have go to market strategies.
CONTACT US
LOOKING FOR A PARTNER WITH KEY INSIGHTS GO TO MARKET STRATEGIES FOR MEDTECH AI TECHNOLOGY?
OUR LAST THREE PROJECTS WERE:
What price premium can be charged for an upgraded legacy product in a commodity space?
Medtech price sensitivity analysis - hospital administrators and CFOs
M&A due diligence analysis: pricing for a new disruptive product